Abstract:Lipid metabolism in cancer cells has garnered increasing attention in recent decades. Cancer cells thrive in hypoxic conditions, nutrient deficiency, and oxidative stress and cannot be separated from alterations in lipid metabolism. Therefore, cancer cells exhibit increased lipid metabolism, lipid uptake, lipogenesis and storage to adapt to a progressively challenging environment, which contribute to their rapid growth. Lipids aid cancer cell activation. Cancer cells absorb lipids with the help of transporter and translocase proteins to obtain energy. Abnormal levels of a series of lipid synthases contribute to the over-accumulation of lipids in the tumor microenvironment (TME). Lipid reprogramming plays an essential role in the TME. Lipids are closely linked to several immune cells and their phenotypic transformation. The reprogramming of tumor lipid metabolism further promotes immunosuppression, which leads to immune escape. This event significantly affects the progression, treatment, recurrence, and metastasis of cancer. Therefore, the present review describes alterations in the lipid metabolism of immune cells in the TME and examines the connection between lipid metabolism and immunotherapy.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the impact of lipid metabolism reprogramming in the tumor microenvironment (Tumor Microenvironment, TME) on tumor immunotherapy. Specifically, the author explores the following aspects: 1. **Changes in lipid metabolism in tumor cells**: - In order to adapt to harsh conditions such as hypoxia, nutrient deficiency, and oxidative stress, tumor cells will reprogram their lipid metabolism to increase lipid absorption, synthesis, and storage. These changes contribute to the rapid growth and survival of tumor cells. - Changes in lipid metabolism not only affect the tumor cells themselves but also other cells in the tumor microenvironment, such as immune cells. 2. **Lipid metabolism and the function of immune cells**: - Different types of immune cells show different metabolic preferences in the tumor microenvironment. For example, M1 - type macrophages (M1 - TAMs) prefer glycolysis, while M2 - type macrophages (M2 - TAMs) prefer fatty acid oxidation (FAO). - Changes in lipid metabolism can affect the function of immune cells, leading to immunosuppression and thus promoting tumor immune escape. For example, excessive fatty acid and cholesterol accumulation can lead to a decline in CD8+ T - cell function, while linoleic acid (LA) and short - chain fatty acids (SCFAs) can enhance T - cell activity. 3. **The impact of lipid metabolism reprogramming on immunotherapy**: - Tumor cells escape the surveillance of the immune system through lipid metabolism reprogramming, which leads to a reduced sensitivity to immune checkpoint inhibitors (such as PD - 1 antibodies). - The combined use of small - molecule drugs targeting lipid metabolism and immunotherapy can improve the treatment effect and enhance the sensitivity to radiotherapy and chemotherapy. 4. **The role of lipid metabolism in different immune cells**: - The paper describes in detail the role of lipid metabolism in macrophages, T cells, dendritic cells (DCs), and natural killer cells (NK cells). For example, lipid accumulation can affect the function of DCs, leading to a decline in their antigen - presenting ability, which in turn affects the activation of T cells. In summary, this paper aims to comprehensively describe the mechanism of lipid metabolism reprogramming in the tumor microenvironment and its impact on immunotherapy, and propose new treatment methods targeting lipid metabolism to improve the effectiveness of existing immunotherapy.

Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy

Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer and metastasis

Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy

Contradictory roles of lipid metabolism in immune response within the tumor microenvironment

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

Lipid Metabolism Regulation Based on Nanotechnology for Enhancement of Tumor Immunity

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications

A Forgotten Corner in Cancer Immunotherapy: the Role of Lipids

Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment

Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy

Lipid Metabolism in Cancer Progression and Therapeutic Strategies

Lipid metabolic features of T cells in the Tumor Microenvironment

Lipid metabolism in tumor microenvironment: novel therapeutic targets

Regulation of CD8+ T cells by lipid metabolism in cancer progression

Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy

Lipids in the tumor microenvironment: immune modulation and metastasis

Metabolic interventions: A new insight into the cancer immunotherapy

The Role of Tumor Metabolic Reprogramming in Tumor Immunity

Targeting lipid metabolism of macrophages: A new strategy for tumor therapy

Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer

Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy